Anahí Dreser

851 total citations
36 papers, 542 citations indexed

About

Anahí Dreser is a scholar working on Economics and Econometrics, Applied Microbiology and Biotechnology and Finance. According to data from OpenAlex, Anahí Dreser has authored 36 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Economics and Econometrics, 11 papers in Applied Microbiology and Biotechnology and 9 papers in Finance. Recurrent topics in Anahí Dreser's work include Pharmaceutical Economics and Policy (13 papers), Antibiotic Use and Resistance (11 papers) and Healthcare Systems and Reforms (9 papers). Anahí Dreser is often cited by papers focused on Pharmaceutical Economics and Policy (13 papers), Antibiotic Use and Resistance (11 papers) and Healthcare Systems and Reforms (9 papers). Anahí Dreser collaborates with scholars based in Mexico, United States and Netherlands. Anahí Dreser's co-authors include Veronika J. Wirtz, Ralph Gonzales, Yared Santa‐Ana‐Téllez, Aukje K. Mantel‐Teeuwisse, Hubert G. M. Leufkens, Michael R. Reich, Monique Elseviers, Robert Vander Stichele, E. Vázquez‐Vélez and René Leyva Flores and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and BMJ.

In The Last Decade

Anahí Dreser

31 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anahí Dreser Mexico 13 258 120 107 102 95 36 542
Caijun Yang China 14 274 1.1× 161 1.3× 93 0.9× 110 1.1× 81 0.9× 36 510
Hanne Bak Pedersen Denmark 11 210 0.8× 318 2.6× 98 0.9× 64 0.6× 95 1.0× 24 718
Ali Hassan Gillani China 14 240 0.9× 146 1.2× 96 0.9× 126 1.2× 68 0.7× 40 628
Dan Kibuule Namibia 17 301 1.2× 183 1.5× 187 1.7× 128 1.3× 124 1.3× 69 838
Martha Gyansa‐Lutterodt Ghana 13 207 0.8× 165 1.4× 125 1.2× 32 0.3× 148 1.6× 20 550
Yu Fang China 13 191 0.7× 141 1.2× 79 0.7× 134 1.3× 74 0.8× 33 584
Sri Suryawati Indonesia 13 269 1.0× 106 0.9× 150 1.4× 101 1.0× 236 2.5× 40 997
P.C. Joshi India 7 359 1.4× 73 0.6× 99 0.9× 96 0.9× 85 0.9× 9 560
Muhammad Majid Aziz China 12 264 1.0× 65 0.5× 93 0.9× 154 1.5× 67 0.7× 32 521
Sewunet Admasu Belachew Ethiopia 18 209 0.8× 91 0.8× 128 1.2× 191 1.9× 153 1.6× 43 906

Countries citing papers authored by Anahí Dreser

Since Specialization
Citations

This map shows the geographic impact of Anahí Dreser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anahí Dreser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anahí Dreser more than expected).

Fields of papers citing papers by Anahí Dreser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anahí Dreser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anahí Dreser. The network helps show where Anahí Dreser may publish in the future.

Co-authorship network of co-authors of Anahí Dreser

This figure shows the co-authorship network connecting the top 25 collaborators of Anahí Dreser. A scholar is included among the top collaborators of Anahí Dreser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anahí Dreser. Anahí Dreser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santa‐Ana‐Téllez, Yared, Anahí Dreser, Lucila I. Castro‐Pastrana, et al.. (2025). Electronic data sources for drug utilization research and healthcare decision-making in Mexico. BMC Health Services Research. 25(1). 1214–1214.
2.
Lichtenberger, Paola N., et al.. (2025). Point Prevalence Survey of Antibiotic Use in Latin American Hospitals: 2022–2023. Antibiotics. 14(11). 1078–1078.
3.
Dreser, Anahí, et al.. (2024). Analyzing One Health governance and implementation challenges in Mexico. Global Public Health. 19(1). 2377259–2377259. 2 indexed citations
4.
Orozco, Emanuel, et al.. (2024). Challenges to the development of taxation policies for sugar-sweetened beverages in Colombia. BMJ Global Health. 8(Suppl 8). e012074–e012074. 1 indexed citations
5.
Flores‐Hernández, Sergio, et al.. (2024). Calidad de la atención de los servicios de salud. Salud Pública de México. 66(4, jul-ago). 570–579.
6.
Wirtz, Veronika J., et al.. (2023). Misinformation messages shared via WhatsApp in Mexico during the COVID-19 pandemic: an exploratory study. Health Promotion International. 38(3). 1 indexed citations
7.
Dreser, Anahí, et al.. (2021). The implementation of pharmaceutical services in public hospitals in Mexico: an analysis of the legal framework and organizational practice. Journal of Pharmaceutical Policy and Practice. 14(1). 41–41. 8 indexed citations
8.
Ewen, Margaret, Anahí Dreser, Sergio Bautista‐Arredondo, et al.. (2020). Availability, prices, and affordability of selected essential cancer medicines in a middle-income country – the case of Mexico. BMC Health Services Research. 20(1). 424–424. 19 indexed citations
9.
Reyes‐Morales, Hortensia, et al.. (2019). Análisis y reflexiones sobre la iniciativa de reforma a la Ley General de Salud de México 2019. Salud Pública de México. 61(5, sep-oct). 685–685. 15 indexed citations
10.
Dreser, Anahí, et al.. (2019). Access to cancer medication in public hospitals in a middle-income country: The view of stakeholder. Research in Social and Administrative Pharmacy. 16(9). 1255–1263. 5 indexed citations
11.
Reyes‐Morales, Hortensia, et al.. (2017). Condiciones de trabajo en consultorios adyacentes a farmacias privadas en Ciudad de México: perspectiva del personal médico. Gaceta Sanitaria. 31(6). 459–465. 5 indexed citations
12.
Wirtz, Veronika J., Edson Serván‐Mori, Ileana Heredia-Pi, Anahí Dreser, & Leticia Ávila‐Burgos. (2013). Factores asociados con la utilización y el gasto en medicamentos en México. Salud Pública de México. 55(2). 112–122. 4 indexed citations
13.
Santa‐Ana‐Téllez, Yared, Aukje K. Mantel‐Teeuwisse, Anahí Dreser, Hubert G. M. Leufkens, & Veronika J. Wirtz. (2013). Impact of Over-the-Counter Restrictions on Antibiotic Consumption in Brazil and Mexico. PLoS ONE. 8(10). e75550–e75550. 98 indexed citations
14.
Dreser, Anahí, et al.. (2012). Regulation of antibiotic sales in Mexico: an analysis of printed media coverage and stakeholder participation. BMC Public Health. 12(1). 1051–1051. 33 indexed citations
15.
Wirtz, Veronika J., Anahí Dreser, & Ralph Gonzales. (2010). Trends in antibiotic utilization in eight Latin American countries, 1997-2007. Revista Panamericana de Salud Pública. 27(3). 219–25. 108 indexed citations
16.
Wirtz, Veronika J., Katja Taxis, & Anahí Dreser. (2008). Pharmacy customers’ knowledge of side effects of purchased medicines in Mexico. Tropical Medicine & International Health. 14(1). 93–100. 13 indexed citations
17.
Gonzales, Ralph, Kitty Corbett, Veronika J. Wirtz, & Anahí Dreser. (2008). A shrinking window of opportunity. BMJ. 336(7650). 948.2–949. 4 indexed citations
18.
Dreser, Anahí, Veronika J. Wirtz, Kitty Corbett, & Gabriela Echániz-Avilés. (2008). Uso de antibióticos en México: revisión de problemas y políticas Antibiotic use in Mexico: review of problems and policies. SHILAP Revista de lepidopterología. 1 indexed citations
19.
Wirtz, Veronika J., Michael R. Reich, René Leyva Flores, & Anahí Dreser. (2008). Medicines in Mexico, 1990-2004: systematic review of research on access and use. Salud Pública de México. 50. S470–S479. 20 indexed citations
20.
Dreser, Anahí, Veronika J. Wirtz, Kitty Corbett, & Gabriela Echániz-Avilés. (2008). Uso de antibióticos en México: revisión de problemas y políticas. Salud Pública de México. 50. S480–S487. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caijun Yang Breakdown of academic impact, for papers by Hanne Bak Pedersen Breakdown of academic impact, for papers by Ali Hassan Gillani Breakdown of academic impact, for papers by Dan Kibuule Breakdown of academic impact, for papers by Martha Gyansa‐Lutterodt Breakdown of academic impact, for papers by Yu Fang Breakdown of academic impact, for papers by Sri Suryawati Breakdown of academic impact, for papers by P.C. Joshi Breakdown of academic impact, for papers by Muhammad Majid Aziz Breakdown of academic impact, for papers by Sewunet Admasu Belachew
Rankless by CCL
2026